GRHPR Gene Hyperoxaluria Type 2 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines

تحليل جين GRHPR لفرط أكسالات البول من النوع الثاني بالتسلسل الجيني NGS في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي

الملخص التنفيذي

دقة تشخيصية مضمونة بنسبة 99.9% عبر معالجة معتمدة وفق معايير الأيزو.
خدمة سحب دم منزلي بمستوى المستشفيات عبر سلسلة تبريد معتمدة من الأيزو، وخدمة الفصد المنزلي المتميزة.
استشارة سريرية هاتفية بعد الفحص لتوجيه تفسير النتائج.
التحقق المباشر من التغطية التأمينية عبر واتساب على الرقم +971 54 548 8731.

Clinical Overview & Precision Diagnostics

The GRHPR Gene Hyperoxaluria Type 2 Genetic Test employs next-generation sequencing to detect pathogenic variants in the GRHPR gene, offering unparalleled accuracy for diagnosing primary hyperoxaluria type 2—a rare metabolic disorder causing recurrent kidney stones and renal failure. This test is faster and more comprehensive than traditional Sanger sequencing, providing full gene coverage within 3–4 weeks.

Feature	Our NGS Test	Closest Alternative (Sanger Sequencing)
Diagnostic Sensitivity	99.9% (full gene analysis)	~85% (targeted hotspot only)
Turnaround Time	3–4 Weeks	6–8 Weeks
Detection of Novel Variants	Yes (whole coding region)	Limited
Compliance	ISO 9001:2015, DHA accredited	Variable

Physician Insight & Safety Protocol

“As a clinician, I understand the anxiety that accompanies genetic testing for a condition like hyperoxaluria. This NGS‑based assay provides a definitive molecular diagnosis, but results must always be correlated with your clinical picture and family history. Never alter any prescribed medication without consulting your nephrologist.” — Dr. PRABHAKAR REDDY, DHA License: 61713011

⚠ Important Medication Warning:

Do not discontinue prescribed medications (e.g., pyridoxine, citrate supplements, or diuretics) without consulting your doctor. This genetic test is for diagnostic clarification only and does not replace ongoing medical management.

Exclusion Criteria & Emergency Red Flags

This test is not designed for acute emergency diagnosis; if you experience sudden severe flank pain, blood in urine, or inability to urinate, seek immediate ER care.
Exclusion: Patients unable to provide informed consent, or specimens with gross hemolysis compromising DNA quality.
Genetic counseling is mandatory before sample collection; incomplete family pedigree information may delay interpretation.

Frequently Asked Questions

What is the GRHPR gene and why is this test performed?

The GRHPR gene test sequences the entire coding region to identify mutations causing primary hyperoxaluria type 2, confirming diagnosis and guiding targeted therapy.

ما هو اختبار جين GRHPR ولماذا يُجرى؟ يقوم الاختبار بتسلسل الجين الكامل لتحديد الطفرات المسببة لفرط أكسالات البول من النوع الثاني، مما يؤكد التشخيص ويوجه العلاج.

How is the sample collected and is home collection available?

Sample collection requires a simple blood draw (or oral swab) performed by a certified phlebotomist; we offer VIP home collection with cold-chain transport across all Emirates.

كيف يتم جمع العينة وهل تتوفر خدمة السحب المنزلي؟ يتم سحب عينة دم بسيطة أو مسحة فموية عبر فني معتمد؛ نوفر خدمة السحب المنزلي الفاخر مع النقل المبرد لجميع الإمارات.

What do positive results mean for my health management?

A positive result confirms hereditary hyperoxaluria type 2, enabling early nephrological intervention, personalized stone prevention, and family screening strategies.

ماذا تعني النتيجة الإيجابية لصحتك؟ تؤكد النتيجة الإيجابية الإصابة الوراثية بفرط أكسالات البول النوع الثاني، مما يتيح التدخل الكلوي المبكر والوقاية الشخصية وفحص أفراد الأسرة.

Pre‑ Requirements & Genetic Counselling

A detailed clinical history and a genetic counselling session to construct a three‑generation pedigree chart of family members affected with Hyperoxaluria Type 2 are mandatory prior to testing. This ensures accurate interpretation and adherence to UAE CDS Law 2026 for minors.

This service complies with Federal Decree-Law No. 41 of 2024 (Art. 87), UAE Personal Data Protection Law, and CDS Law 2026 for minors. Our laboratory holds ISO 9001:2015 certification (INT/EGQ/2509DA/3139) and DHA facility license 9834453. For insurance verification, WhatsApp +971 54 548 8731. Results are interpreted under DHA-licensed clinical supervision.

All genetic data is processed under strict PDPL compliance, using encrypted data storage and limited access protocols.

دعم ثنائي اللغة متاح